Chadman, The broker that I referred to has spoken to representatives of the company several times over the last few months and none of the developments that he was told about have come to pass. Not info to "bank on" but something to keep in mind unless you are asleep at the switch!
The company has ONE iron in the fire (IMHO) which will bring in revenue in the next couple of years and that is synDNA. The company stated in their quarterly that they expect to lose money regardless of synDNA sales due to the expenses of other research, which means that share price will be a big factor in future funding of company projects.
I'm glad you can wait until after Labor Day because no one wants your shares now except the MMs. Oh by the way, your shares are going somewhere, they are going down.
You are right that we are not talking about "dinky things" here. We are talking about very expensive research projects that will need further funding from the sales of stock if synDNA sales can't carry the load. With the SP where it is, the next PPO should be at about 35 cents.
I want this to work as much as anyone else, but with this managements record with corporate comunications, I plan to dig up all the info I can so as not to end up a total bag-holder if this deal doesn't fly. I also HOPE very much that we have a winner here. Take care.
News 
Market Data 
Discover 
AI
